REPLY: Reply Crypto Investment Challenge Kicks Off, Organised by Reply and Young Platform, to Promote Conscious Investment in Digital Assets
7.4.2023 10:00:00 EEST | Business Wire | Press release
The fourth edition of the Reply Investment Challenge kicks off, focusing for the first time on Digital Assets, Crypto, and Blockchain. Aimed at students and young professionals, the international online competition in 2022 counted 13,750 entries from 95 countries around the world and a total volume of 36,000 trades executed.
The objective of the Challenge, which will take place from Monday 8 May to Friday 19 May 2023, will be to bring participants closer to the world of digital assets and Blockchain, promoting an informed use of these financial instruments and paying particular attention to the issue of portfolio diversification. Players will also be able to choose between two different interfaces: a more simple and more intuitive one and a more complete and detailed one, respectively Young Platform and Young Platform Pro.
Participants will be able to practice until 5 May in a protected environment, expanding their skills on digital financial instruments, and in particular on cryptocurrencies, as well as on the Blockchain as an enabling technology. The virtual capital of EUR 1 million that each player will have at their disposal will be made available at the time of registration, and all transactions will be conducted at current market values. In the month leading up to the competition, moreover, on the Challenge platform, all participants will be able to access exclusive e-learning content, created by Reply, Young Platform and POLIMI Graduate School of Management.
At the start of the competition, on 8 May, the participants' wallets will be re-credited with the virtual sum of € 1,000,000 to be invested in real-time and the challenge can begin. Challengers will be ranked and evaluated based on their investment choices and the strategy implemented in response to the suggestions published by Reply. Only the top three, i.e. those who, more than the others, have succeeded in maximising their portfolio's return through diversification, will win the competition.
This year Reply has chosen Young Platform, Italy's largest regulated cryptocurrency platform, as its partner. Young Platform is a Turin-based scale-up founded in 2018 to make the cryptocurrency market accessible to all. The platform acts as a point of reference for those who want to use digital assets in a simple, transparent, and effective way, even without having specific expertise in the sector. It stands out for its focus on security, training, and the privacy of its users, guaranteeing the use of cutting-edge technologies to protect data and transactions.
Reply, thanks to its expertise in Blockchain and distributed technology, supports various financial institutions, as well as major players in sectors such as healthcare, energy & utilities, fashion & luxury, and others, in the adoption of digital assets, thus positioning itself as a reference player in the Crypto and Blockchain field.
The POLIMI Graduate School of Management, with its participation in the Reply Crypto Investment Challenge, confirms its commitment to educating and training risk-conscious financial operators in investments.
The Reply Crypto Investment Challenge is part of Reply's Challenges program, which, together with the Masters in Digital Finance at POLIMI Graduate School of Management and in AI & Cloud at the Politecnico di Torino and the Reply Code For Kids program, are just some of the examples that bear witness to Reply's commitment to the development of innovative training models, capable of involving the new generations. Today Reply's Challenges have a community of over 140,000 players.
Registration for the Reply Crypto Investment Challenge is open until 5 May 2023. All information is available at: challenges.reply.com.
Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Young Platform
Young Platform is a Turin-based scale-up founded in 2018 to make the cryptocurrency market accessible to everyone. The platform acts as a reference point for those who want to use cryptocurrencies in a simple, transparent, and effective way, even without having specific expertise in the field. Young Platform offers a wide range of tools and services, including the possibility to buy and sell cryptocurrencies and earn tokens using learning games, and advanced trading tools. The platform stands out for its focus on the security and privacy of its users, guaranteeing the use of state-of-the-art technology to protect data and transactions, relying exclusively on Italian banks. Young Platform considers compliance a priority aspect of technological innovation. For this reason, it has always been committed to developing cutting-edge solutions to manage the risk of financial crime and to structuring specialised blockchain intelligence aimed at combating money laundering and the financing of terrorism, working with regulators and law enforcement agencies. Young Platform is the first company officially registered with the Organismo Agenti e Mediatori (OAM) in Italy and was recently certified as a digital asset services operator (PSAN) by the French Financial Markets Authority.
POLIMI Graduate School of Management
At POLIMI Graduate School of Management, we inspire tomorrow's business leaders and the companies they work in, knowing that they can play a crucial role in creating a better future for everyone. Indeed, we believe that education is of fundamental importance, as it provides tomorrow's leaders with the skills and experience they will need to tackle the most important challenges facing our society. Our School, founded over 40 years ago in Milan as MIP Politecnico di Milano, is today a non-profit joint-stock consortium, made up of the University and a group of leading Italian and international companies. We offer more than 40 master's degrees, including MBAs and Executive MBAs, a catalog of over 200 open programs, and tailor-made training courses for companies. We are innovative and always want to be more so. That is why today our Online MBA is recognised as one of the best in the world and why the digital component is present in all our training offerings. As part of the School of Management, we are one of the few schools in the world to have achieved 'Triple Crown' accreditation. With more than 15,000 Alumni and 3,000 students each year, we are a large, innovative, and entrepreneurial community of people and partners. For us, relationships are a source of constant enrichment, innovation, and inspiration, both personally and professionally. For us, the issue of sustainability is really important and we strive to build a better, fairer, more inclusive, and conscious future. We do this with projects and initiatives that maximise our positive impact on society. This is why, in 2020, we were the first European business school to receive the B Corp certification. www.gsom.polimi.it
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230407005004/en/
Contact information
Media contacts:
R
eply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594
Aaron Miani
a.miani@reply.com
Tel. +44 2077 306000
Young Platform
Jacqueline Nieder
j.nieder@young.business
Tel. +39 349 3091984
POLIMI Graduate School of Management
Sergio Oliveri
+39 338 5617836
oliveri@mip.polimi.it
L45 Corporate Relations
Alessandro D’Angelo
+39 329 4139226
adangelo@l45.it
Hind Misbah
+39 329 5425659
hind@l45.it
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
